Hoechst Pharmaceuticals Llp

Founded in 2022 and headquartered in Delhi, India.

2022 | North West Delhi, Delhi (India) | Active
Last Updated: June 06, 2024

Hoechst Pharmaceuticals Llp Profile

Key Indicators

  • Obligation of Contribution ₹ 0.10 M
  • Company Age 2 Year, 8 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 1.93 M

About Hoechst Pharmaceuticals Llp

Hoechst Pharmaceuticals Llp (HPL) is 2 Year, 8 Months old Limited Liability Partnership 12 May 2022. Its registered office is in North West Delhi, Delhi, India.

The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.

Company Details

  • Location

    North West Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN/FCRN

    ABA-9921

  • Incorporation Date

    12 May 2022

  • Date of Accounts and Solvency Statement

    31 Mar 2023

  • ROC Code

    Roc-Delhi

  • Company Classification

    Limited Liability Partnership

Industry

Business Services

Who are the key members and board of directors at Hoechst Pharmaceuticals Llp?

Designated Partners (2)

Name Designation Appointment Date Status
Kapil Jain Country flag representing In Designated Partner 12-May-2022 Current
Soniya Soniya Designated Partner 12-May-2022 Current

Financial Performance of Hoechst Pharmaceuticals Llp.

Enhance accessibility to Hoechst Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Hoechst Pharmaceuticals Llp?

Unlock access to Hoechst Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹1.93 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 0.19 Cr

Latest Charge Details

Date Lender Amount Status
02 Jan 2023 Hdfc Bank Limited ₹1.93 M Open

How Many Employees Work at Hoechst Pharmaceuticals Llp?

Unlock and access historical data on people associated with Hoechst Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hoechst Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hoechst Pharmaceuticals Llp's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Hoechst Pharmaceuticals Llp

Recent activity within the organization

  • Statement of Assets & Liabilities

    Hoechst Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Delhi.

    31 Mar 2023

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.93 M with Charge ID 100757322 was registered on 02 Jan 2023.

    02 Jan 2023

  • Director Appointment

    Kapil Kumar Bhawarlal Jain was appointed as a Designated Partner was appointed as a Designated Partner on 12 May 2022 & has been associated with this company since 2 years 8 months .

    12 May 2022

  • Director Appointment

    Soniya Soniya was appointed as a Designated Partner was appointed as a Designated Partner on 12 May 2022 & has been associated with this company since 2 years 8 months .

    12 May 2022

  • LLP Incorporation

    Hoechst Pharmaceuticals Llp was registered on 12 May 2022 with RoC-Delhi & aged 2 years 8 months as per MCA records.

    12 May 2022

Frequently asked questions

  • Hoechst Pharmaceuticals Llp was incorporated on 12 May 2022.

  • The Obligation of Contribution of Hoechst Pharmaceuticals Llp is ₹ 0.10 M.

  • Currently 2 partners are associated with Hoechst Pharmaceuticals Llp.

    • Kapil Kumar Bhawarlal Jain
    • Soniya Soniya
    Kapil Kumar Bhawarlal JainSoniya Soniya
  • As per Ministry of Corporate Affairs (Mca), the registered address of Hoechst Pharmaceuticals Llp is No. A-62, Situated At Pushpanjali Enclave Pitampura Rani Bagh North West, North West Delhi, India, 110034.

  • The Limited Liability Partnership Identification Number (LLPIN) of Hoechst Pharmaceuticals Llp is ABA-9921.

  • As per the financial statements for fiscal Year 0, The total open charges for Hoechst Pharmaceuticals Llp amount to ₹ 1.93 M.

  • The most recent Balance Sheet for Hoechst Pharmaceuticals Llp was filed with the ROC on 31 Mar 2023.